Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Spinal Cord Injury

Phase 1/2 Unknown 50 enrolled Chaitanya Hospital, Pune

NaSingle-groupOpen-labelTreatment

Summary

This Study is a single arm,Phase I/II , single centre trial to check active comparing the safety and efficacy of Bone marrow derived autologous cell(100 million per dose) trial to be conducted for 36 months.

Timeline

Start: 2014-09
Primary completion: 2016-09
Completion: 2016-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Autologous stem cell [MNCs]	Unknown	1e+08 cells	Intrathecal

Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Spinal Cord Injury

Summary

Timeline

Drugs

Indications